Nivolumab Maintenance for Aggressive B-Cell Lymphoma in Remission After First Line Therapy: A Phase 2 Clinical Trial

Research output: Contribution to journal › Letter › peer-review

Original language	English
Journal	European Journal of Haematology
DOIs	https://doi.org/10.1111/ejh.70132
State	Accepted/In press - 2026
Externally published	Yes

Access to Document

@article{7a165c3c8b7e4103a023c097f4f4eba9,

title = "Nivolumab Maintenance for Aggressive B-Cell Lymphoma in Remission After First Line Therapy: A Phase 2 Clinical Trial",

author = "Meirav Kedmi and Elena Ribakovsky and Tzvika Porges and Ohad Benjamini and Avichai Shimoni and Abraham Avigdor",

year = "2026",

doi = "10.1111/ejh.70132",

language = "אנגלית",

journal = "European Journal of Haematology",

issn = "0902-4441",

publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - Nivolumab Maintenance for Aggressive B-Cell Lymphoma in Remission After First Line Therapy

T2 - A Phase 2 Clinical Trial

AU - Kedmi, Meirav

AU - Ribakovsky, Elena

AU - Porges, Tzvika

AU - Benjamini, Ohad

AU - Shimoni, Avichai

AU - Avigdor, Abraham

PY - 2026

Y1 - 2026

UR - https://www.scopus.com/pages/publications/105029749146

U2 - 10.1111/ejh.70132

DO - 10.1111/ejh.70132

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 41668621

AN - SCOPUS:105029749146

SN - 0902-4441

JO - European Journal of Haematology

JF - European Journal of Haematology

ER -